SCHEMBL8636455

SCHEMBL8636455

CS(=O)(=O)n1ccnc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.45
KDM4E B2RXH2 1/20 0.41
CHEK1 O14757 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
LIMK1 P53667 1/20 0.41
MAPK14 Q16539 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HTR6 P50406 1/20 0.40
LIMK2 P53671 1/20 0.39
PTGS2 P35354 2/20 0.39
ELAVL1 Q15717 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
PLAA Q9Y263 1/20 0.38
TSHR P16473 2/20 0.37
PTGS1 P23219 1/20 0.37
KDR P35968 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29023643 0.81 ESR1 (0.49) ESR1KDM4ECHEK1ALDH1A1MAPT
SCHEMBL24696570 0.81 ESR1 (0.45) ESR1KDM4ECHEK1ALDH1A1MAPT
SCHEMBL5316947 0.80 PTGS2 (0.43) KDM4EALDH1A1MAPTPTGS2NPC1
SCHEMBL723626 0.80 MET (0.51) ESR1ALDH1A1HTR6LIMK2NR1H2
SCHEMBL28303263 0.78 L3MBTL1 (0.54) KDM4EALDH1A1MAPTNR1H2NR1H3
SCHEMBL5535962 0.77 ESR1 (0.42) ESR1KDM4ECHEK1ALDH1A1MAPT
SCHEMBL770698 0.75 L3MBTL1 (0.50) ALDH1A1MAPTHTR6NR1H2NR1H3
SCHEMBL15041407 0.74 RECQL (0.45) KDM4EALDH1A1HTR6RAB9ATSHR
SCHEMBL28219756 0.74 PKM (0.52) KDM4EALDH1A1MAPTHTR6LIMK2
SCHEMBL28219334 0.74 MEN1 (0.50) ALDH1A1MAPTHTR6LIMK2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0941080-A2 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS G.D. SEARLE & CO. (US) 1999-09-15 EP disclosed
EP-0880504-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-12-02 EP disclosed
WO-1998022101-A2 METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS AS ANTI-ANGIOGENIC AGENTS G.D. SEARLE & CO. (US) 1998-05-28 WO disclosed
WO-1997027181-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-07-31 WO disclosed